DUBLIN--(BUSINESS WIRE)--The "Global virus filteration Market Research Report, Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023" report has been added to ResearchAndMarkets.com's offering.
The global virus filtration market is expected to rise with the CAGR of about 12% during forecast period. Rising demand for biological products such as vaccines, cellular & gene therapy, etc. is one of the major factor which contributes to growth of global virus filtration market during forecast period.
Also, growth in pharmaceutical industry as well as rise in research & development in biologic contributes to the market growth. However, stringent regulations for validation of filtration products and highly consolidated market are the factors restraining growth of virus filtration market during forecast period.
The growth in global virus filtration market is also influenced by the presence of major players such as Merck group (Germany), Danaher Corporation (U.S.), Sartorius AG (Germany), Thermo Fisher Scientific (U.S.), Wuxi Pharmatech (Cayman) Inc. (China), etc. Product launches, mergers & acquisitions, joint ventures, collaboration etc. are some crucial strategies that are adopted by the major players to gain competitive advantage.
The report covers segmentation analysis of product, technology, application and end users. Further, the report covers segments of product which include consumables, instruments and services. Consumables accounted for the largest market revenue share in 2016 and it is expected to dominate the market during the forecast period due to increased usage of consumables such as reagents, membranes, etc. in biologic downstream processing. Technologies involved in virus filtration include filtration and chromatography. Further, applications of virus filtration include biological, medical devices, water purification and air purification.
Chromatography is expected to be the fastest growing segment during the forecast period due to advancements in product such as development of single use membranes. Furthermore, the end users adopting virus filtration include biopharmaceutical & biotechnology companies, contract research organizations, medical devices companies and academic institutes & research laboratories.
Key Topics Covered
2. Market Overview
3. Market Determinants
4. Market Segmentation
5. Competitive Landscape
6. Geographic Analysis
7. Company Profiles
- Argonide (U.S.)
- Asahi Kasei Medical Co., Ltd. (Japan)
- Charles River Laboratories (U.S.)
- Clean Cells Inc. (France)
- Danaher Corporation (U.S.)
- GE Healthcare (U.K.)
- Lenntech (The Netherlands)
- Lonza Group (Switzerland)
- Merck Group (Germany)
- Pendotech (U.S.)
- Sartorius Ag (Germany)
- Thermo Fisher Scientific (U.S.)
- Wuxi Pharmatech (Cayman) Inc. (China)
For more information about this report visit https://www.researchandmarkets.com/research/pv63pw/global_virus?w=4